GEN stock forecast
Our latest prediction for Genesis Healthcare, Inc.'s stock price was made on the June 3, 2019 when the stock price was at 1.15$.
In the short term (2weeks), GEN's stock price should outperform the market by 1.17%. During that period the price should oscillate between -6.56% and +12.19%.
In the medium term (3months), GEN's stock price should outperform the market by 10.14%. During that period the price should oscillate between -15.27% and +35.63%.Get email alerts
Create a solid portfolio with GEN
About Genesis Healthcare, Inc.
Genesis Healthcare, Inc. is a holding company, which engages in the provision of inpatient services through skilled nursing and assisted and senior living communites. It also offers rehabilitation and respiratory therapy services. It operates through the following segments: Inpatient Services, Rehabilitation Therapy Services, and Other Services. The Inpatient Services segment manages operation of skilled nursing facilities and assisted/senior living facilities. The Rehabilitation Therapy Services segment provides rehabilitation and respiratory therapy services. The Other Services segment comprises of other specialty medical services, including physician services, staffing services, and other healthcare related services. The company was founded in 1985 and is headquartered in Kennett Square, PA.
At the moment the company generates 4566M USD in revenues.
On its last earning announcement, the company reported a profit of 0.10$ per share.
The book value per share is -7.53$
Three months stock forecastJune 3, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|